BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
3.960
-0.020 (-0.50%)
Jun 16, 2026, 2:00 PM CET
Market Cap341.74M -4.1%
Revenue (ttm)266.02M +12.8%
Net Income4.05M
EPS0.05
Shares Out 85.86M
PE Ratio84.50
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume28,605
Open3.980
Previous Close3.980
Day's Range3.920 - 3.985
52-Week Range3.650 - 4.700
Beta0.17
Analystsn/a
Price Target5.65 (+42.68%)
Earnings DateSep 15, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements